Pieris Pharmaceuticals Inc (PIRS) Net Margin

Graphic logo of Pieris Pharmaceuticals Inc (PIRS)

High fixed testing costs create risks reflected in the current sales margin level; 0.00 captures the current value of the indicator. Stephen Yarrow's search for new partners to optimize the portfolio restores stability. Outsourcing drug production to specialized contract organizations provides additional support, reducing capital burdens on the R&D infrastructure of Pieris Pharmaceuticals (PIRS).

Pieris Pharmaceuticals (PIRS) - Company Sales Margin from 07/04/2022 to 11/19/2026

Pieris Pharma (PIRS) - metric breakdowns and financial figures

- share price and expert price forecast:
General company analysis:Pieris Pharmaceuticals, Inc. - PIRS
Finished products of Pieris

Sales margins determine the share of net profit in every dollar of revenue, reflecting the overall efficiency of the business. An investor utilizes the company's net margin ratio to assess real profitability, avoiding impulsive purchases at local peaks. This indicator reveals the asset's ability to generate profit after all expenses. For Pieris Pharmaceuticals (PIRS), this confirms financial stability during the development of anti-kallikreins. The brand's scientific authority in oncology ensures the viability of such calculations.

Who Pieris Pharmaceuticals competes with

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|Company Sales Margin Entera Bio|Net Sales Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Net Margin|Cumberland Corp - Net Sales Margin|QNTM - Net Sales Margin|FibroGen, Inc. (FGEN) - Net Margin|TELO: Company Net Profitability|RANI (Rani Therapeutics Inc) - Net Sales Margin|Net Margin synergychc.com SNYR|Net Margin Rallybio Corp. (RLYB)|LEXX - Net Margin|Net Sales Margin PULM (pulmatrix.com)|Company Net Profitability PTHL (Pheton)|APM - Net Margin|Company Sales Margin Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Net Margin|TNF Pharma (TNFA) - Net Sales Margin|YCBD (cbdmd.com) - Net Sales Margin|Return on Sales by Net Profit PainReform (PRFX)|Net Margin Altamira Therapeutics (CYTO)|Company Sales Margin Lipella Pharma|Optinose - Return on Sales by Net Profit|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma